Saturday, February 25, 2006


Hepatitis C Virus Lives In Your Liver(NC)-Your liver (Hepatitis C Treatment Options)

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>


Friday, February 24, 2006


Hepatitis C Treatment Options - Pharmacy Benefit


Pharmacy Benefit
Managed Healthcare Executive - HEPATITIS B AND C are serious viral diseases that can lead to lifelong infection, cirrhosis, liver cancer, liver failure and death. They often produce chronic, hidden infections. An estimated 1.25 million Americans are infected with hepatitis B, and

CROI: Rapid response predicts success in HIV/HCV coinfected patients
Aidsmap - Virological response to hepatitis C therapy after four weeks appears to predict who will have a successful response to a full course of treatment in HIV-positive people coinfected with hepatitis C genotypes 1 or 3, according to findings from two

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Novartis And Idenix Seek European Approval Of Telbivudine (LDT600) For
Medical News Today - Novartis and Idenix Pharmaceuticals, Inc. announced today the European submission of telbivudine (LTD600) for approval as a novel treatment for patients affected by chronic hepatitis B (CHB), a potentially fatal disease estimated to affect more than

Hepatitis-C (Hepatitis C Treatment Options)


Hepatitis-C
hepatitis c

Hepatitis C and Chimpanzees
Americans For Medical Advancement. Europeans For Medical Advancement. Japanese For Medical Advancement. Hepatitis C and Chimpanzees. Are chimpanzees useful in HCV research? ... Hepatitis C. Hepatitis C infection is estimated to have infected 3% of the population of the planet or 170-200 ...

Hepatitis Information Network: Hepatitis C
News, epidemiology, natural history, and notes on the management and treatment of the disease.

Thursday, February 23, 2006


Victim of tainted blood scandal puts human face on criminal trial (Hepatitis C Treatment Options)


Victim of tainted blood scandal puts human face on criminal trial
Philadelphia Inquirer - TORONTO - James Kreppner, his legal career halted when he contracted HIV and Hepatitis C through tainted blood, sat in the back of a courtroom Wednesday, putting a human face on a criminal trial resulting from Canada's worst public health scandal

Hepatitis C - silent epidemic
Thunder Bay Source - It's being called the silent epidemic by those that deal with it on a day-to-day basis. The incidence of Hepatitis C is rising in Northwestern Ontario and alarmingly at a much higher rate than the rest of the province. To help bring the issue to the

'Silent killer' driven out of the shadows: Hepatitis
Chillico Gazette - There was a time when Arline Loh of Wilmington, Del., didn't tell people she has hepatitis B. "It carries such a stigma," says Loh, 57, an information technology expert who retired three months ago because of liver damage caused by the disease

Daily Planner: Monday
Chico Enterprise-Record - BLOOD DRIVE: Donor hours 8 a.m.-1 p.m. Saturday; 8 a.m.-3 p.m. Monday and Wednesday; 11 a.m.-6 p.m. Tuesday and Thursday; 7 a.m.-2 p.m. Friday. BloodSource, 555 Rio Lindo Ave., Chico. 893-5433. Weekly. BUTTE COUNTY COORDINATING COUNCIL: 11:15 a.m.-1

Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C (Hepatitis C Treatment Options)


Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 15 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin Anti-Viral in the treatment of chronic hepatitis C virus infection .Save to My Web

Tuesday, February 21, 2006


Hepatitis C Treatment Options - Hepatitis C, Enzymsch den, Stoffwechselst rungen, Enzephalopathie - Translate this page


Hepatitis C, Enzymsch den, Stoffwechselst rungen, Enzephalopathie - Translate this page
Die Seite zum Thema Hepatitis C,Enzymsch den,Stoffwechselst rungen,toxische Enzephalopathie,SPECT,PET ... Zusammenh ngen zwischen der Infektionserkrankung Hepatitis C / Umwelt- belastungen und Stoffwechselerkrankungen ...

A Hepatitis C Primer
Resource for anyone wanting to learn more about the virus. Includes medical research as well as personal experiences.

Hepatitis C Virus (HCV): Hep C Support
Learn More About Hepatitis C Virus (HCV) and Hep C Support ... Hear from patients about their experiences with hepatitis C ... This free program strengthens your confidence in hepatitis C therapy. Learn about Be In Charge ...

The Hepatitis Information Network
Offers information on risk factors, frequently asked questions, current developments, a survey, and more.

Hepatitis C Treatment Options - Hepatitis C -- Management of special groups: HBV-HCV Coinfection


Hepatitis C -- Management of special groups: HBV-HCV Coinfection
LINKS FOR THIS SECTION. Management of Special Groups: HCV-HBV Coinfection. KEY POINTS ... suggested that active HBV infection suppresses the replication of HCV. A recent review of serologic and ... a large group of anti-HCV-positive patients found a significantly lower ...

An Examination of HCV and Co-Existing Medical Conditions
This article describes how patients who have HIV, hemophilia, kidney disease, diabetes, and/or another form of hepatitis may be predisposed to infection with the hepatitis C virus. ... and diabetes have a higher rate of infection with the hepatitis C virus (HCV) than the general population ... a common transmission route with HCV, such as other hepatitis viruses (such ...

AEGiS-MMWR: Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic ...
These recommendations are an expansion of previous recommendations for the prevention of hepatitis C virus (HCV) infection that focused on screening and follow-up of blood, plasma, organ, tissue, and semen donors (CDC. Public Health Service inter... Alanine aminotransferase. Anti-HCV Antibody to HCV that develops in response to HCV ...

SN03-23
... in a reusable Hypersonic Cruise Vehicle (HCV). This autonomous aircraft would be capable of ... Government is interested in innovative HCV concepts that utilize novel technologies that ...

HCV Treatment May Improve Outcome in Splenic Lymphoma
In this small study, interferon helpful only in patients with HCV infection. ... may respond to treatment for hepatitis C virus (HCV), according to results of a small comparative study ...

Hepatitis C Treatment Options - Research and Clinical Trials: Chronic Hepatitis C End-Stage


Research and Clinical Trials: Chronic Hepatitis C End-Stage
Study to Compare the Efficacy and Safety Among Three Immunosuppressant Treatment Regimens in Patients Receiving a Liver Transplant for End-Stage Liver Disease Caused by Chronic Hepatitis C Infection

Medscape Resource Center - Hepatitis C
Feb 10, 2006 - Antihypertensive drug losartan may reduce liver fibrosis in patients with chronic hepatitis C infection who do not respond to the standard antiviral therapy, the results of a pilot

CASL Hepatology Fellowship
Hepatitis C infection occurs in HIV-positive patients with a frequency between 50-90%. Co-infection results in hepatitis C viral loads that are higher than in the absence of HIV ( 99,100

The Land of Waz and Hepatitis C
Chronic hepatitis C infection is also associated with many autoimmune diseases (where the body develops antibodies which attack parts of itself). For example, about one-tenth of people with chronic

Monday, February 20, 2006


USDA Funded Projects


USDA Funded Projects
... disease distribution will be applied to newly emeerged diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. ...

THE CONTRIBUTIONS OF NONHUMAN PRIMATE RESEARCH TO HUMAN HEALTH
... Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975.Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. ...

Main
- [ Translate this page ]... HBV-pNq clinically from the serum of the patient with g type´ Viral heaptitis by ~lOmg/K` body weight per day. the seven patients (23´0) among 30 chosen ...

Sunday, February 19, 2006


Hepatitis C Top Articles (Hepatitis C Treatment Options)


Hepatitis C Top Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines for chronic hepatitis B. ... with PEG-Intron in adult subjects who have chronic hepatitis C without cirrhosis, and who have failed an ... doses used for treatment of chronic hepatitis C was enough to eradicate ...

Neumega May Have Role in Treatment of Chronic Hepatitis C
... reduce hepatic inflammation in patients with chronic hepatitis C who have failed anti-viral ... inflammation have not been evaluated in patients with chronic hepatitis C infection ...

Hepatitis C Complete health information regarding HCV on MedicineNet.com
Learn and become aware of Hepatitis C includes a complete description of the virus, transmission, prevention, symptoms, diagnosis, and forms of treatment. ... Once established, chronic hepatitis C virus infection causes an inflammation of the liver called chronic ... due to the complications of chronic hepatitis C virus liver disease is ...

Hepatitis C
... Chronic Hepatitis C. Hepatitis C is a cause for concern for two reasons ... that about 20% of the patients with chronic hepatitis C will develop cirrhosis, and a few of ...

Hospital Practice: Chronic Hepatitis C: Early Intervention
Chronic Hepatitis C: Early Intervention. RAYMOND S. KOFF. University of Massachusetts ... Chronic hepatitis C infection is the most common liver disease in the United States; it accounts for up to 12,000 deaths ...